Prestige Consumer Healthcare (PBH) Revenue & Revenue Breakdown
Prestige Consumer Healthcare Revenue Highlights
Latest Revenue (Y)
$1.13B
Latest Revenue (Q)
$283.55M
Main Segment (Y)
Women's Health
Main Geography (Y)
North American OTC Healthcare
Prestige Consumer Healthcare Revenue by Period
Prestige Consumer Healthcare Revenue by Year
Date | Revenue | Change |
---|---|---|
2024-03-31 | $1.13B | -0.21% |
2023-03-31 | $1.13B | 3.76% |
2022-03-31 | $1.09B | 15.21% |
2021-03-31 | $943.37M | -2.04% |
2020-03-31 | $963.01M | -1.31% |
2019-03-31 | $975.78M | -6.28% |
2018-03-31 | $1.04B | 18.04% |
2017-03-31 | $882.06M | 9.40% |
2016-03-31 | $806.25M | 12.82% |
2015-03-31 | $714.62M | 18.73% |
2014-03-31 | $601.88M | -3.48% |
2013-03-31 | $623.60M | 41.38% |
2012-03-31 | $441.08M | 31.08% |
2011-03-31 | $336.51M | 11.42% |
2010-03-31 | $302.02M | -3.42% |
2009-03-31 | $312.71M | -4.25% |
2008-03-31 | $326.60M | 2.50% |
2007-03-31 | $318.63M | 7.40% |
2006-03-31 | $296.67M | -2.19% |
2005-03-31 | $303.32M | 244.99% |
2004-03-31 | $87.92M | 22.56% |
2003-03-31 | $71.73M | 55.09% |
2002-03-31 | $46.25M | 434.41% |
2001-03-31 | $8.65M | - |
Prestige Consumer Healthcare Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | $283.55M | 6.14% |
2024-06-30 | $267.14M | -3.56% |
2024-03-31 | $276.99M | -2.03% |
2023-12-31 | $282.74M | -1.25% |
2023-09-30 | $286.32M | 2.51% |
2023-06-30 | $279.31M | -2.29% |
2023-03-31 | $285.87M | 3.75% |
2022-12-31 | $275.52M | -4.75% |
2022-09-30 | $289.27M | 4.41% |
2022-06-30 | $277.06M | 3.79% |
2022-03-31 | $266.94M | -2.74% |
2021-12-31 | $274.47M | -0.64% |
2021-09-30 | $276.23M | 2.62% |
2021-06-30 | $269.18M | 13.21% |
2021-03-31 | $237.76M | -0.43% |
2020-12-31 | $238.79M | 0.58% |
2020-09-30 | $237.42M | 3.50% |
2020-06-30 | $229.39M | -8.69% |
2020-03-31 | $251.24M | 4.01% |
2019-12-31 | $241.55M | 1.46% |
2019-09-30 | $238.07M | 2.55% |
2019-06-30 | $232.15M | -3.68% |
2019-03-31 | $241.03M | -0.16% |
2018-12-31 | $241.41M | 0.86% |
2018-09-30 | $239.36M | -5.76% |
2018-06-30 | $253.98M | -0.78% |
2018-03-31 | $255.97M | -5.41% |
2017-12-31 | $270.62M | 4.88% |
2017-09-30 | $258.03M | 0.57% |
2017-06-30 | $256.57M | 6.61% |
2017-03-31 | $240.67M | 11.03% |
2016-12-31 | $216.76M | 0.80% |
2016-09-30 | $215.05M | 2.61% |
2016-06-30 | $209.57M | 0.83% |
2016-03-31 | $207.85M | 3.83% |
2015-12-31 | $200.19M | -2.85% |
2015-09-30 | $206.06M | 7.25% |
2015-06-30 | $192.13M | 1.10% |
2015-03-31 | $190.05M | -3.83% |
2014-12-31 | $197.61M | 9.01% |
2014-09-30 | $181.27M | 24.41% |
2014-06-30 | $145.70M | 1.00% |
2014-03-31 | $144.26M | -1.34% |
2013-12-31 | $146.21M | -13.20% |
2013-09-30 | $168.44M | 17.82% |
2013-06-30 | $142.97M | -7.47% |
2013-03-31 | $154.51M | -3.57% |
2012-12-31 | $160.23M | -1.00% |
2012-09-30 | $161.85M | 10.11% |
2012-06-30 | $147.00M | 9.70% |
2012-03-31 | $134.00M | 26.11% |
2011-12-31 | $106.25M | 0.67% |
2011-09-30 | $105.54M | 10.76% |
2011-06-30 | $95.30M | -1.11% |
2011-03-31 | $96.36M | 6.35% |
2010-12-31 | $90.61M | 15.71% |
2010-09-30 | $78.30M | 6.64% |
2010-06-30 | $73.42M | 2.86% |
2010-03-31 | $71.38M | -5.39% |
2009-12-31 | $75.45M | -10.37% |
2009-09-30 | $84.18M | 14.96% |
2009-06-30 | $73.22M | 3.35% |
2009-03-31 | $70.85M | -11.74% |
2008-12-31 | $80.28M | -8.83% |
2008-09-30 | $88.05M | 19.74% |
2008-06-30 | $73.53M | -8.58% |
2008-03-31 | $80.43M | - |
Prestige Consumer Healthcare Revenue Breakdown
Prestige Consumer Healthcare Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
Analgesics | $117.45M | - | - | - | - |
Cough and Cold | $119.02M | - | - | - | - |
Dermatologicals | $129.10M | - | - | - | - |
Eye and Ear Care | $179.42M | - | - | - | - |
Gastrointestinal | $231.61M | - | - | - | - |
Oral Care | $96.31M | - | - | - | - |
Other OTC | $12.03M | - | - | - | - |
Women's Health | $240.42M | - | - | - | - |
Product and Service, Other | - | $107.00K | $42.00K | $41.00K | $74.00K |
Product | - | $1.13B | $1.09B | $943.32M | $962.94M |
Latest
Quarterly Revenue by Product
Product/Service | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Analgesics | $28.22M | $55.82M | $30.27M | $31.36M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Women's Health | $60.35M | $120.08M | $58.27M | $62.07M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Other OTC | $3.16M | $6.17M | $3.11M | $2.75M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Oral Care | $24.08M | $50.06M | $23.46M | $22.78M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gastrointestinal | $60.06M | $117.22M | $61.63M | $52.76M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Eye and Ear Care | $42.79M | $87.48M | $45.07M | $46.87M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Dermatologicals | $35.85M | $66.85M | $27.77M | $34.49M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cough and Cold | $29.27M | $52.61M | $33.17M | $33.23M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Product | - | - | - | - | $279.30M | $285.83M | $275.50M | $289.26M | $277.02M | $266.93M | $274.45M | $276.22M | $269.17M | $237.75M | $238.78M | $237.41M | $229.38M | $251.21M | $241.54M | $238.05M |
Product and Service, Other | - | - | - | - | $10.00K | $34.00K | $29.00K | $9.00K | $35.00K | $9.00K | $16.00K | $8.00K | $9.00K | $9.00K | $9.00K | $13.00K | $10.00K | $28.00K | $7.00K | $18.00K |
Latest
Prestige Consumer Healthcare Revenue Breakdown by Country
Annual Revenue by Country
Country | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
North American OTC Healthcare | $958.26M | - | - | - | - |
Non-US | - | $174.50M | $176.71M | $144.33M | $150.36M |
UNITED STATES | - | $953.22M | $910.11M | $799.04M | $812.65M |
Latest
Quarterly Revenue by Country
Country | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
North American OTC Healthcare | $239.81M | $422.32M | $236.56M | $244.42M | $54.95M | $242.32M | $53.92M | $59.38M | $61.18M | - | - | - | - | - | - | - | - | - | - | - |
Non-US | - | - | - | - | - | - | - | - | - | $47.36M | $46.76M | $40.07M | $42.51M | $38.65M | $41.49M | $34.13M | $30.05M | $42.84M | $37.63M | $38.35M |
UNITED STATES | - | - | - | - | - | - | - | - | - | $219.57M | $227.72M | $236.15M | $226.67M | $199.11M | $197.30M | $203.29M | $199.35M | $208.39M | $203.92M | $199.71M |
Latest
Prestige Consumer Healthcare Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
PBH | Prestige Consumer Healthcare | $1.13B | $283.55M |
PAHC | Phibro Animal Health | $977.89M | $273.16M |
EVO | Evotec SE | $781.43M | $208.73M |
PCRX | Pacira BioSciences | $674.98M | $168.57M |
SUPN | Supernus Pharmaceuticals | $607.52M | $175.69M |
AMPH | Amphastar Pharmaceuticals | $593.24M | $188.82M |
COLL | Collegium Pharmaceutical | $566.77M | $159.30M |
ANIP | ANI Pharmaceuticals | $486.82M | $148.33M |
EGRX | Eagle Pharmaceuticals | $316.61M | $64.65M |
DCPH | Deciphera Pharmaceuticals | $163.36M | $45.00M |
SSIC | Silver Spike Investment | $11.72M | $2.76B |
RGC | Regencell Bioscience | - | - |